
CAS 1541172-75-1
:(S)-N-((S)-1-(((2R,4S)-1,2-Diidroxi-2,6-dimetil-3-oxoheptan-4-il)amino)-1-oxo-3-fenilpropan-2-il)-4-metil-2-((S)-2-(2-morfolinoacetamido)-4-fenilbutanamido)pentanamida
- (S)-N-((S)-1-(((2R,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pe
- PR-519
- Kyprolis Impurity V
- L-Phenylalaninamide, (αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S,3R)-3,4-dihydroxy-3-methyl-1-(2-methylpropyl)-2-oxobutyl]-
- (S)-N-((S)-1-(((2R,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
(S)-N-((S)-1-(((2R,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
CAS:(S)-N-((S)-1-(((2R,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
Pureza:95%Peso molecular:737.93g/molCarfilzomib Impurity 2 (PR-519M16, Carfilzomib (2R,4S)-Diol)
CAS:Fórmula:C40H59N5O8Cor e Forma:White To Off-White SolidPeso molecular:737.94Carfilzomib (2R,4S)-Diol
CAS:Produto ControladoApplications Carfilzomib (2R,4S)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);Fórmula:C40H59N5O8Cor e Forma:NeatPeso molecular:737.93Carfilzomib (2S,4S)-Diol Hydrochloride
CAS:Produto ControladoFórmula:C40H59N5O8•HClCor e Forma:NeatPeso molecular:774.39Carfilzomib (2R,4S)-diol
CAS:Carfilzomib is a drug product that belongs to the class of drugs called proteasome inhibitors. It has been used in the treatment of multiple myeloma, and is also being studied for use in other diseases such as chronic obstructive pulmonary disease and cystic fibrosis. Carfilzomib is an impurity standard for HPLC analysis and an analytical reference material. It is also used as a pharmacopoeia reference material. Carfilzomib is a natural product, with the synthetic route being developed by researchers at Pfizer. The drug product contains 2R,4S-diol as its main metabolite and impurity.
Fórmula:C40H59N5O8Pureza:Min. 95%Peso molecular:737.90 g/mol





